Mitsubishi UFJ Trust & Banking Corp Has $123.39 Million Stake in Aetna Inc. (AET)
Mitsubishi UFJ Trust & Banking Corp raised its position in Aetna Inc. (NYSE:AET) by 3.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 812,696 shares of the company’s stock after buying an additional 30,477 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.25% of Aetna worth $123,392,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. raised its position in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares during the period. Vanguard Group Inc. raised its position in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the period. FMR LLC raised its position in shares of Aetna by 2.2% in the first quarter. FMR LLC now owns 7,903,233 shares of the company’s stock worth $1,008,059,000 after buying an additional 167,261 shares during the period. Bank of New York Mellon Corp raised its position in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after buying an additional 165,278 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of Aetna by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,962,514 shares of the company’s stock worth $505,399,000 after buying an additional 21,953 shares during the period. Institutional investors own 91.69% of the company’s stock.
Shares of Aetna Inc. (AET) opened at 156.10 on Friday. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $161.69. The firm has a market capitalization of $51.84 billion, a price-to-earnings ratio of 34.65 and a beta of 0.54. The stock’s 50 day moving average price is $155.24 and its 200-day moving average price is $141.63.
Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 earnings per share. On average, equities research analysts predict that Aetna Inc. will post $9.55 EPS for the current fiscal year.
AET has been the subject of a number of analyst reports. Stifel Nicolaus reiterated a “buy” rating and set a $150.00 price target (up previously from $130.00) on shares of Aetna in a research report on Wednesday, May 3rd. Royal Bank Of Canada boosted their price target on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research report on Friday, June 9th. BidaskClub lowered Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Deutsche Bank AG boosted their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, UBS AG reiterated a “buy” rating and set a $160.00 price target (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Seven investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $157.99.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.